Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

2.94
-0.4700-13.78%
Post-market: 2.93-0.0100-0.34%19:59 EDT
Volume:701.51K
Turnover:2.15M
Market Cap:13.23M
PE:-0.14
High:3.22
Open:3.20
Low:2.94
Close:3.41
52wk High:67.12
52wk Low:2.34
Shares:4.50M
Float Shares:4.50M
Volume Ratio:0.16
T/O Rate:15.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.7848
EPS(LYR):-22.3665
ROE:-1802.45%
ROA:-110.27%
PB:-6.19
PE(LYR):-0.13

Loading ...

Company Profile

Company Name:
bioAffinity Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
57
Office Location:
3300 Nacogdoches Road,Suite 216,San Antonio,Texas,United States
Zip Code:
78217
Fax:
- -
Introduction:
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

Directors

Name
Position
Maria Zannes
President, Chief Executive Officer and Director
Steven Girgenti
Executive Chairman of the Board
Jamie Platt
Independent Director
Peter Knight
Independent Director
Robert Anderson
Independent Director
John J. Oppenheimer
Director
Roberto Rios
Director
Roby P. Joyce
Director

Shareholders

Name
Position
Maria Zannes
President, Chief Executive Officer and Director
Xavier Trinidad Reveles
Chief Operating Officer
Michael Edwards
Chief Financial Officer and Principal Accounting Officer
Steven Girgenti
Executive Chairman of the Board
Timothy P. Zannes
Executive Vice President, Secretary and General Counsel